HARVARD AT HOME - SHOULD ALEXA DIAGNOSE ALZHEIMER'S
THIS VIRTUAL EVENT will explore the medical, legal, and ethical implications of using such technologies.
Date: Friday, February 11, 2022
Place: THIS IS A VIRTUAL EVENT
Technology is now part of our lives in ways that were not possible only ten or twenty years ago. Smart devices, like watches, phones, and speakers, can gather vast amounts of information about their users, often without the user’s knowledge or consent.
As technology continues to improve, many of these devices may also be leveraged to serve diagnostic functions. Technologies such as Amazon’s Alexa and Google’s Assistant can ambiently and continually monitor a variety of information about an individual’s location, voice, and movement. As this technology merges with wearables, such as the Apple Watch or FitBit, it may become possible to diagnose a wide range of diseases, including Alzhiemer’s. But should it?
To help answer that question, Dr. Barbara Evans, Professor of Law and Engineering at the University of Florida, and Dr. Jason Karlawish , Professor of Medicine at the University of Pennsylvannia, will discuss the medical, legal, and ethical implications of using such technology to diagnose diseases, such as Alzhiemer’s.
ADDITIONAL DETAILS can be found on the Harvard Law School website by CLICKING HERE.
Organizer: The Harvard Medical School Center for Bioethics and the
at Brigham and Women's Hospital, in collaboration with the
Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
Registration: Register by CLICKING HERE